These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio™) in controlling fleas in client-owned dogs in European countries. Cavalleri D; Murphy M; Seewald W; Drake J; Nanchen S Parasit Vectors; 2017 Nov; 10(1):526. PubMed ID: 29089065 [TBL] [Abstract][Full Text] [Related]
25. Comparative speed of kill of sarolaner (Simparica Packianathan R; Hodge A; Bruellke N; Davis K; Maeder S Parasit Vectors; 2017 Feb; 10(1):98. PubMed ID: 28222813 [TBL] [Abstract][Full Text] [Related]
26. A randomized, blinded, controlled USA field study to assess the use of fluralaner tablets in controlling canine flea infestations. Meadows C; Guerino F; Sun F Parasit Vectors; 2014 Aug; 7():375. PubMed ID: 25129395 [TBL] [Abstract][Full Text] [Related]
27. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio Forster S; Wiseman S; Snyder DE Parasit Vectors; 2021 Jun; 14(1):299. PubMed ID: 34088338 [TBL] [Abstract][Full Text] [Related]
28. A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe. Cavalleri D; Murphy M; Seewald W; Nanchen S Parasit Vectors; 2018 Jul; 11(1):410. PubMed ID: 30001744 [TBL] [Abstract][Full Text] [Related]
29. Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio Becskei C; Willesen JL; Schnyder M; Wozniakiewicz M; Miroshnikova N; Mahabir SP Parasit Vectors; 2020 Jul; 13(1):385. PubMed ID: 32727548 [TBL] [Abstract][Full Text] [Related]
30. Comparative speed of kill of sarolaner (Simparica and fluralaner (Bravecto) against induced infestations of Ctenocephalides felis on dogs. Six RH; Liebenberg J; Honsberger NA; Mahabir SP Parasit Vectors; 2016 Feb; 9():92. PubMed ID: 26896436 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA. Dryden MW; Smith V; Chwala M; Jones E; Crevoiserat L; McGrady JC; Foley KM; Patton PR; Hawkins A; Carithers D Parasit Vectors; 2015 May; 8():286. PubMed ID: 26003175 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the curative and preventive efficacy of a single oral administration of afoxolaner against cat flea Ctenocephalides felis infestations on dogs. Hunter JS; Dumont P; Chester TS; Young DR; Fourie JJ; Larsen DL Vet Parasitol; 2014 Apr; 201(3-4):207-11. PubMed ID: 24629423 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA. Dryden MW; Canfield MS; Kalosy K; Smith A; Crevoiserat L; McGrady JC; Foley KM; Green K; Tebaldi C; Smith V; Bennett T; Heaney K; Math L; Royal C; Sun F Parasit Vectors; 2016 Jun; 9(1):365. PubMed ID: 27352607 [TBL] [Abstract][Full Text] [Related]
34. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs. Rohdich N; Roepke RK; Zschiesche E Parasit Vectors; 2014 Mar; 7():83. PubMed ID: 24593931 [TBL] [Abstract][Full Text] [Related]
35. Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard against induced infestations of Ixodes scapularis on dogs. Six RH; Young DR; Myers MR; Mahabir SP Parasit Vectors; 2016 Feb; 9():79. PubMed ID: 26876891 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of a new topical formulation of selamectin plus sarolaner for the control of fleas and ticks infesting cats in Japan. Yonetake W; Fujii T; Naito M; Hodge A; Maeder S; Rugg D Vet Parasitol; 2019 Jun; 270 Suppl 1():S12-S18. PubMed ID: 30914264 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs. Six RH; Becskei C; Carter L; Gale B; Young DR; Mahabir SP; Chapin S; Myers MR Vet Parasitol; 2016 May; 222():23-7. PubMed ID: 26961589 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs. Six RH; Geurden T; Packianathan R; Colgan S; Everett WR; Grace S; Hodge A; Mahabir SP; Myers MR; Slootmans N; Davis K Vet Parasitol; 2016 May; 222():18-22. PubMed ID: 26935820 [TBL] [Abstract][Full Text] [Related]
39. Curative and preventive efficacy of orally administered afoxolaner against Ctenocephalides canis infestation in dogs. Dumont P; Gale B; Chester TS; Larsen DL Vet Parasitol; 2014 Apr; 201(3-4):212-5. PubMed ID: 24631503 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of a new spot-on formulation of selamectin plus sarolaner in the treatment of naturally occurring flea and tick infestations in cats presented as veterinary patients in Europe. Geurden T; Becskei C; Farkas R; Lin D; Rugg D Vet Parasitol; 2017 Apr; 238 Suppl 1():S12-S17. PubMed ID: 28395750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]